Altus Pharmaceuticals Reacquires ALTU-238 Global Development and Commercialzation Rights.

Business Wire › December 19, 2007

Linked as:

Extract

Altus Pharmaceuticals Reacquires ALTU-238 Global Development and Commercialzation Rights.

CAMBRIDGE, Mass. -- Altus Pharmaceuticals Inc. (NASDAQ: ALTU) announced today that it has reacquired ALTU-238 development and commercialization rights for North America from Genentech, Inc. Also, the Company announced that the exclusive optio...

See the full content of this document

Sponsored links

ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Language

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company

Other documents:

Titan Pharmaceuticals Announces Milestone Payment From Schering AG in Development Program for Spheramine. | Berkshire Partners' Ferenbach Named Chairman of English Welsh & Scottish Railway. | desde la bahÃa. | NANOPIERCE TECHNOLOGIES Collaborates With Industry Leader ORGA on Smart Card Ve... | Decisión de Tribunal Segundo de Primera Instancia en Funciones de Control de Tachira Extensión S... | Decisión de Juzgado Segundo de Primera Instancia Civil y Mercantil de Monagas de July 21 2006 | Decisión nº 2.080-05 de Tribunal Décimo de Control de Zulia Extensión Maracaibo de December 01 2005 | decisión de tribunal cuarto de primera instancia en funciones de control de tachira (extensión san cristóbal...